222 top medical experts on Lafora Disease across 30 countries and 11 U.S. states, including 32 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Lafora Disease: A form of stimulus sensitive myoclonic epilepsy inherited as an autosomal recessive condition. The most common presenting feature is a single seizure in the second decade of life. This is followed by progressive myoclonus, myoclonic seizures, tonic-clonic seizures, focal occipital seizures, intellectual decline, and severe motor and coordination impairments. Most affected individuals do not live past the age of 25 years. Concentric amyloid (Lafora) bodies are found in neurons, liver, skin, bone, and muscle (From Menkes, Textbook of Childhood Neurology, 5th ed, pp111-110).
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Progressive Myoclonic Epilepsies (1,240), Nervous System Heredodegenerative Disorders (865).
  4. Clinical Trials ClinicalTrials.gov : at least 2 including 1 Completed
  5. Synonyms: Lafora Progressive Myoclonic Epilepsy,  Lafora Type Progressive Myoclonic Epilepsy


  

        

                    


    Computing Expert Listing ...

);